ZEVRA THERAPEUTICS, INC. (ZVRA) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $475K. Most recent filing: Aug. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 17, 2026 filed Aug. 14, 2026 | Thompson Rahsaan Chief Legal & Compliance | −$474,774 | 42,666 | −53% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Watton Corey Michael Director | $77,246 | 36,900 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 21, 2026 | Thompson Rahsaan Chief Legal & Compliance | — | +32,110 | +67% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free